সুইজারল্যান্ড - জার্মান - Swissmedic (Swiss Agency for Therapeutic Products)

ingenus pharmaceuticals gmbh - doxorubicini hydrochloridum - 10 mg, lyophilisat - vorbereitung cryodesiccata: doxorubicini hydrochloridum 10 mg, lactosum monohydricum, für glas. - zytostatika - synthetika

সুইজারল্যান্ড - জার্মান - Swissmedic (Swiss Agency for Therapeutic Products)

ingenus pharmaceuticals gmbh - doxorubicini hydrochloridum - 20 mg, lyophilisat - vorbereitung cryodesiccata: doxorubicini hydrochloridum 20 mg, lactosum monohydricum, für glas. - zytostatika - synthetika

সুইজারল্যান্ড - জার্মান - Swissmedic (Swiss Agency for Therapeutic Products)

ingenus pharmaceuticals gmbh - doxorubicini hydrochloridum - 50 mg, lyophilisat - vorbereitung cryodesiccata: doxorubicini hydrochloridum 50 mg, lactosum monohydricum, für glas. - zytostatika - synthetika

জার্মানি - জার্মান - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

bb farma s.r.l. (8126628) - doxorubicinhydrochlorid - konzentrat zur herstellung einer infusionslösung - teil 1 - konzentrat zur herstellung einer infusionslösung; doxorubicinhydrochlorid (06460) 2 milligramm

ইউরোপীয় ইউনিয়ন - জার্মান - EMA (European Medicines Agency)

accord healthcare s.l.u. - doxorubicin hydrochloride, liposomal - ovarian neoplasms; sarcoma, kaposi; multiple myeloma - doxorubicin - zolsketil pegylated liposomal is a medicine used to treat the following types of cancer in adults:• breast cancer that has spread to other parts of the body in patients at risk of heart problems. zolsketil pegylated liposomal is used on its own for this disease;• advanced ovarian cancer in women whose previous treatment including a platinum-based cancer medicine has stopped working;• multiple myeloma (a cancer of the white blood cells in the bone marrow), in patients with progressive disease who have received at least one other treatment in the past and have already had, or are unsuitable for, a bone marrow transplantation. zolsketil pegylated liposomal is used in combination with bortezomib (another cancer medicine);• kaposi’s sarcoma in patients with aids who have a very damaged immune system. kaposi’s sarcoma is a cancer that causes abnormal tissue to grow under the skin, on moist body surfaces or on internal organs. zolsketil pegylated liposomal contains the active substance doxorubicin and is a ‘hybrid medicine’. this means that it is similar to a ‘reference medicine’ containing the same active substance called adriamycin. however, in zolsketil pegylated liposomal the active substance is enclosed in tiny fatty spheres called liposomes, whereas this is not the case for adriamycin.

অস্ট্রিয়া - জার্মান - AGES (Agentur für Gesundheit und Ernährungssicherheit)

stada arzneimittel gmbh - doxorubicin hydrochlorid - doxorubicin

অস্ট্রিয়া - জার্মান - AGES (Agentur für Gesundheit und Ernährungssicherheit)

teva pharma b.v. - doxorubicin hydrochlorid - doxorubicin

জার্মানি - জার্মান - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

pharmachemie b.v. (3189127) - doxorubicinhydrochlorid - injektionslösung - teil 1 - injektionslösung; doxorubicinhydrochlorid (06460) 10 milligramm

জার্মানি - জার্মান - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

axionovo gmbh - geschäftsanschrift - (8185708) - doxorubicinhydrochlorid - infusionslösung - teil 1 - infusionslösung; doxorubicinhydrochlorid (06460) 2 milligramm

বেলজিয়াম - জার্মান - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

pfizer - doxorubicin-hydrochlorid - injektionslösung - 10 mg - doxorubicin-hydrochlorid 10 mg - doxorubicin